Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke

<p>Abstract</p> <p>Background</p> <p>Thrombolysis with recombinant tissue plasminogen activator (rtPA) is an established treatment in acute stroke. To prevent rethrombosis after rtPA therapy, secondary anticoagulation with heparin is commonly performed. However, the rec...

Full description

Bibliographic Details
Main Authors: Baumann Gert, Schreiber Stephan J, Sanad Wasiem, Doepp Florian, Borges Adrian C
Format: Article
Language:English
Published: BMC 2005-05-01
Series:Cardiovascular Ultrasound
Subjects:
Online Access:http://www.cardiovascularultrasound.com/content/3/1/14
_version_ 1819044081819451392
author Baumann Gert
Schreiber Stephan J
Sanad Wasiem
Doepp Florian
Borges Adrian C
author_facet Baumann Gert
Schreiber Stephan J
Sanad Wasiem
Doepp Florian
Borges Adrian C
author_sort Baumann Gert
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Thrombolysis with recombinant tissue plasminogen activator (rtPA) is an established treatment in acute stroke. To prevent rethrombosis after rtPA therapy, secondary anticoagulation with heparin is commonly performed. However, the recommended time-point and extent of heparin treatment vary and are not well investigated.</p> <p>Case presentation</p> <p>We report a 61-year-old man who developed an acute global aphasia and right-sided hemiparesis. Cranial CT was normal and systemic thrombolytic therapy with tPA was started 120 minutes after symptom onset. Low-dose subcutaneous heparin treatment was initiated 24 hours later. Transthoracic echocardiography (TTE) 12 hours after admission showed slightly reduced left ventricular ejection fraction (LVEF) but was otherwise normal. 48 hours later the patient suddenly deteriorated with clinical signs of dyspnea and tachycardia. TTE revelead a large left ventricular apical thrombus as well as a reduction of LVEF to 20 %. Serial further TTE investigations demonstrated a complete resolution of the thrombus and normalisation of LVEF within two days.</p> <p>Conclusion</p> <p>Our case demonstrates an intracardiac thrombus formation following rtPA treatment of acute stroke, probably caused by secondary hypercoagulability. Rethrombosis or new thrombus formation might be an underestimated complication of rtPA therapy and potentially explain cases of secondary stroke progression.</p>
first_indexed 2024-12-21T10:07:01Z
format Article
id doaj.art-481c5ca798084f9aaa0b05a1e0be6c6d
institution Directory Open Access Journal
issn 1476-7120
language English
last_indexed 2024-12-21T10:07:01Z
publishDate 2005-05-01
publisher BMC
record_format Article
series Cardiovascular Ultrasound
spelling doaj.art-481c5ca798084f9aaa0b05a1e0be6c6d2022-12-21T19:07:49ZengBMCCardiovascular Ultrasound1476-71202005-05-01311410.1186/1476-7120-3-14Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic strokeBaumann GertSchreiber Stephan JSanad WasiemDoepp FlorianBorges Adrian C<p>Abstract</p> <p>Background</p> <p>Thrombolysis with recombinant tissue plasminogen activator (rtPA) is an established treatment in acute stroke. To prevent rethrombosis after rtPA therapy, secondary anticoagulation with heparin is commonly performed. However, the recommended time-point and extent of heparin treatment vary and are not well investigated.</p> <p>Case presentation</p> <p>We report a 61-year-old man who developed an acute global aphasia and right-sided hemiparesis. Cranial CT was normal and systemic thrombolytic therapy with tPA was started 120 minutes after symptom onset. Low-dose subcutaneous heparin treatment was initiated 24 hours later. Transthoracic echocardiography (TTE) 12 hours after admission showed slightly reduced left ventricular ejection fraction (LVEF) but was otherwise normal. 48 hours later the patient suddenly deteriorated with clinical signs of dyspnea and tachycardia. TTE revelead a large left ventricular apical thrombus as well as a reduction of LVEF to 20 %. Serial further TTE investigations demonstrated a complete resolution of the thrombus and normalisation of LVEF within two days.</p> <p>Conclusion</p> <p>Our case demonstrates an intracardiac thrombus formation following rtPA treatment of acute stroke, probably caused by secondary hypercoagulability. Rethrombosis or new thrombus formation might be an underestimated complication of rtPA therapy and potentially explain cases of secondary stroke progression.</p>http://www.cardiovascularultrasound.com/content/3/1/14thrombolysishypercoagulabilityischemic strokecardiac thrombus
spellingShingle Baumann Gert
Schreiber Stephan J
Sanad Wasiem
Doepp Florian
Borges Adrian C
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
Cardiovascular Ultrasound
thrombolysis
hypercoagulability
ischemic stroke
cardiac thrombus
title Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
title_full Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
title_fullStr Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
title_full_unstemmed Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
title_short Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
title_sort left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
topic thrombolysis
hypercoagulability
ischemic stroke
cardiac thrombus
url http://www.cardiovascularultrasound.com/content/3/1/14
work_keys_str_mv AT baumanngert leftventricularapicalthrombusaftersystemicthrombolysiswithrecombinanttissueplasminogenactivatorinapatientwithacuteischemicstroke
AT schreiberstephanj leftventricularapicalthrombusaftersystemicthrombolysiswithrecombinanttissueplasminogenactivatorinapatientwithacuteischemicstroke
AT sanadwasiem leftventricularapicalthrombusaftersystemicthrombolysiswithrecombinanttissueplasminogenactivatorinapatientwithacuteischemicstroke
AT doeppflorian leftventricularapicalthrombusaftersystemicthrombolysiswithrecombinanttissueplasminogenactivatorinapatientwithacuteischemicstroke
AT borgesadrianc leftventricularapicalthrombusaftersystemicthrombolysiswithrecombinanttissueplasminogenactivatorinapatientwithacuteischemicstroke